Angiogenesis after administration of basic fibroblast growth factor induces proliferation and differentiation of mesenchymal stem cells in elastic perichondrium in an in vivo model: mini review of three sequential republicationabridged reports

• Autorzy: Miyanaga T. , Ueda Y. , Miyanaga A. , Yagishita M. , Hama N.
• Języki publikacji: EN

Abstrakty

EN

To date, studies on mesenchymal tissue stem cells (MSCs) in the perichondrium have focused on in vitro analysis, and the dynamics of cartilage regeneration from the perichondrium in vivo remain largely unknown. We have attempted to apply cell and tissue engineering methodology for ear reconstruction using cultured chondrocytes. We hypothesized that by inducing angiogenesis with basic fibroblast growth factor (bFGF), MSCs or cartilage precursor cells would proliferate and differentiate into cartilage in vivo and that the regenerated cartilage would maintain its morphology over an extended period. As a result of a single administration of bFGF to the perichondrium, cartilage tissue formed and proliferated while maintaining its morphology for at least 3 months. By day 3 post bFGF treatment, inflammatory cells, primarily comprising mononuclear cells, migrated to the perichondrial region, and the proliferation of matrix metalloproteinase 1 positive cells peaked. During week 1, the perichondrium thickened and proliferation of vascular endothelial cells was noted, along with an increase in the number of CD44-positive and CD90-positive cartilage MSCs/progenitor cells. Neocartilage was formed after 2 weeks, and hypertrophied mature cartilage was formed and maintained after 3 months. Proliferation of the perichondrium and cartilage was bFGF concentration-dependent and was inhibited by neutralizing antibodies. Angiogenesis induction by bFGF was blocked by the administration of an angiogenesis inhibitor, preventing perichondrium proliferation and neocartilage formation. These results suggested that angiogenesis may be important for the induction and differentiation of MSCs/cartilage precursor cells in vivo, and that morphological changes, once occurring, are maintained.

• Wydawca: -
• Czasopismo: Cellular and Molecular Biology Letters
• Rocznik: 2018
• Tom: 23
• Opis fizyczny: p.1-17,fig.,ref.

Twórcy

autor

Miyanaga T.

• Department of Plastic and Reconstructive Surgery, Kanazawa Medical University, 1-1 Daigaku, Uchinada-machi, Kahoku-gun, Ishikawa 9200293, Japan

autor

Ueda Y.

• Kanazawa Medical University Hospital, 1-1 Daigaku, Uchinada-machi, Kahoku-gun, Ishikawa 9200293, Japan

autor

Miyanaga A.

• Kanazawa Medical University Hospital, 1-1 Daigaku, Uchinada-machi, Kahoku-gun, Ishikawa 9200293, Japan

autor

Yagishita M.

• Department of Plastic and Reconstructive Surgery, Kanazawa Medical University, 1-1 Daigaku, Uchinada-machi, Kahoku-gun, Ishikawa 9200293, Japan

autor

Hama N.

• Department of Plastic and Reconstructive Surgery, Kanazawa Medical University, 1-1 Daigaku, Uchinada-machi, Kahoku-gun, Ishikawa 9200293, Japan

Bibliografia

• 1. Isogai N, Asamura S, Higashi T, Ikeda Y, Hillyer J, Jacquet R, et al. Tissue engineering of an auricular cartilage model utilizing cultured chondrocyte-poly (L-lactide-epsiloncaprolactone) scaffolds. Tissue Eng. 2004;10:673–87.
• 2. Kobayashi S, Takebe T, Inui M, Iwai S, Kan H, Zheng YW, et al. Reconstruction of human elastic cartilage by a CD44+ CD90+ stem cell in the ear perichondrium. Proc Natl Acad Sci U S A. 2011;108:14479–84.
• 3. Kagimoto S, Takebe T, Kobayashi S, Yabuki Y, Hori A, Hirotomi K, et al. Autotransplantation of monkey ear perichondrium-derived progenitor cells for cartilage reconstruction. Cell Transplant. 2016;25:951–62.
• 4. Takebe T, Kobayashi S, Suzuki H, Mizuno M, Chang YM, Yoshizawa E, et al. Transient vascularization of transplanted human adult-derived progenitors promotes self-organizing cartilage. J Clin Invest. 2014;124:4325–34.
• 5. Togo T, Utani A, Naitoh M, Ohya M, Tsuji Y, Morikawa N, et al. Identification of cartilage progenitor cells in the adult ear perichondrium: utilization for cartilage reconstruction. Lab Investig. 2006;86:445–57.
• 6. Yun YR, Won JE, Jeon E, Lee S, Kang W, Jo H, et al. Fibroblast growth factors: biology, function, and application for tissue regeneration. J Tissue Eng. 2010;7:218142.
• 7. Hu C, Ding Y, Chen J, Liu D, Zhang Y, Ding M, et al. Basic fibroblast growth factor stimulates epithelial cell growth and epithelial wound healing in canine corneas. Vet Opthalmol. 2009;12:170–5.
• 8. Gospodarowics D, Ferrara N, Schweigerer L, Neufeld G. Structural characterization and biological functions of fibroblast growth factor. Endocr Rev. 1987;8:95–114.
• 9. Engvist O, Skoog V, Pastacaldi P, Yormuk E, Juhlin R. The cartilaginous potential of the perichondrium in rabbit ear and rib. A comparative study in vivo and in vitro. Scand J Plast Reconstr Surg Hand Surg. 1979;13:275–80.
• 10. Ohlsen L. Cartilage regeneration from perichondrium. Experimental studies and clinical applications. Plast Reconstr Surg. 1978;62:507–13.
• 11. Arévalo-Silva CA, Cao Y, Vacanti M, Weng Y, Vacanti CA, Eavey RD. Influence of growth factors on tissue engineered pediatric elastic cartilage. Arch Otolaryngol Head Neck Surg. 2000;126:1234–8.
• 12. Arévalo-Silva CA, Cao Y, Weng Y, Vacanti M, Rodríguez A, Vacanti CA, et al. The effect of fibroblast growth factor and transforming growth factor-beta on porcine chondrocytes and tissue-engineered autologous elastic cartilage. Tissue Eng. 2001;7:81–8.
• 13. Zondor SD, Medina PJ. Bevacizumab: an angiogenesis inhibitor with efficacy in colorectal and other malignancies. Ann Pharmacother. 2004;38:1258–64.
• 14. Tol J, Koopman M, Cats A, Rondenburg CJ, Creemers GJ, Schrama JG, et al. Chemotherapy, bevacizumab, and cetuximab in metastatic colorectal cancer. N Engl J Med. 2009;360:563–72.
• 15. Tateno K, Minamino T, Toko H, Akazawa H, Shimizu N, Takeda T, et al. Critical roles of muscle-secreted angiogenic factors in therapeutic neovascularization. Circ Res. 2006;98:1198–202.
• 16. Pepper MS. Extracellular proteolysis and angiogenesis. Thromb Haemost. 2001;86:346–55.
• 17. Raffetto JD, Khalil RA. Matrix metalloproteinases and their inhibitors in vascular remodeling and vascular disease. Biochem Pharmacol. 2008;75:346–59.

Identyfikatory

DOI

10.1186/s11658-018-0113-1